المؤلفون: Salam Saud Alanazi et.al

المصدر: Letters in High Energy Physics, Vol 2024, Iss 1 (2024)

مصطلحات موضوعية: Asthma management, Children, Pharmacological interventions, Inhaled corticosteroids (ICS), Long-acting beta-agonists (LABAs), Leukotriene receptor antagonists (LTRAs), Biologic therapies, Eosinophilic asthma, Inhaler techniques, Treatment adherence, Nuclear and particle physics. Atomic energy. Radioactivity, QC770-798

Relation: https://lettersinhighenergyphysics.com/index.php/LHEP/article/view/1188; https://doaj.org/toc/2632-2714; https://doaj.org/article/61e459f91e1444fa91452a7931b043a6

الاتاحة: https://doaj.org/article/61e459f91e1444fa91452a7931b043a6

المؤلفون: Jorge Arencibia-Borrego, Javier Sanchez Lora, Joan Serra-Batlles, Juan A. Riesco Miranda, Juan Enrique Cimas, Rosa Malo de Molina, Lucía Regadera, Javier Nuevo

المصدر: Medicina Clínica Práctica, Vol 6, Iss 2, Pp 100367- (2023)

مصطلحات موضوعية: Chronic obstructive pulmonary disease, COPD, Long-acting beta-agonists (LABA), Inhaled corticosteroid (ICS), Pressurised metered dose inhaler (pMDI), Medicine (General), R5-920

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2603924923000058; https://doaj.org/toc/2603-9249

URL الوصول: https://doaj.org/article/5ef506b9dd314817bade874d8e03cb54

المؤلفون: I. V. Demko, M. G. Mamaeva, E. A. Sobko, A. Yu. Kraposhina, N. V. Gordeeva

المصدر: Медицинский совет, Vol 0, Iss 21-1, Pp 80-85 (2022)

مصطلحات موضوعية: copd exacerbation, blood eosinophils, long-acting beta-agonists, long-acting anticholinergics, inhaled glucocorticosteroids, Medicine

وصف الملف: electronic resource

Relation: https://www.med-sovet.pro/jour/article/view/6610; https://doaj.org/toc/2079-701X; https://doaj.org/toc/2658-5790

URL الوصول: https://doaj.org/article/fee3226e1cd847e8b61cb908556c941a

المؤلفون: N. V. Trushenko, B. B. Lavginova, G. S. Nuralieva, S. N. Avdeev, Н. В. Трушенко, Б. Б. Лавгинова, Г. С. Нуралиева, С. Н. Авдеев

المصدر: Meditsinskiy sovet = Medical Council; № 20 (2023); 10-17 ; Медицинский Совет; № 20 (2023); 10-17 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: длительнодействующие антагонисты мускариновых рецепторов, combination inhaler, inhaled corticosteroids, long-acting beta-agonists, long-acting anticholinergics, эозинофилия, комбинированные ингаляционные средства, ингаляционные глюкокортикостероиды, длительнодействующие бета2-агонисты

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/7877/6992; Авдеев СН, Айсанов ЗР, Ардашева ТВ, Белевский АС, Демко ИВ, Зайцев АА и др. Хроническая обструктивная болезнь легких: клинические рекомендации. 2023. 100 с. Режим доступа: https://spulmo.ru/upload/kr/HOBL_2023_draft.pdf.; Авдеев СН, Айсанов ЗР, Архипов ВВ, Белевский АС, Визель АА, Демко ИВ и др. Назначение/отмена ингаляционных глюкокортикостероидов у больных хронической обструктивной болезнью легких как терапевтический континуум в реальной клинической практике. Пульмонология. 2023;33(1):109–118. https://doi.org/10.18093/0869-0189-202333-1-109-118.; Авдеев СН, Невзорова ВА, Куделя ЛМ, Кондрашова НМ, Суханова ГИ, Киняйкин МФ и др. Вопросы тройной терапии в лечении хронической обструктивной болезни легких. Комментарии к алгоритму. Резолюция Совета экспертов от 13.06.18 (Владивосток). Пульмонология. 2019;29(3):365–374. https://doi.org/10.18093/0869-0189-2019-29-3-365-374.; Calzetta L, Matera MG, Rogliani P, Cazzola M. The role of triple therapy in the management of COPD. Expert Rev Clin Pharmacol. 2020;13(8):865–874. https://doi.org/10.1080/17512433.2020.1787830.; Ferguson GT, Rabe KF, Martinez FJ, Fabbri LM, Wang C, Ichinose M et al. Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial. Lancet Respir Med. 2018;6(10):747–758. https://doi.org/10.1016/S2213-2600(18)30327-8.; Martinez FJ, Rabe KF, Ferguson GT, Wedzicha JA, Trivedi R, Jenkins M et al. Benefits of budesonide/glycopyrrolate/formoterol fumarate (BGF) on symptoms and quality of life in patients with COPD in the ETHOS trial. Respir Med. 2021;185:106509. https://doi.org/10.1016/j.rmed.2021.106509.; Ishiura Y, Fujimura M, Ohkura N, Hara J, Kasahara K, Ishii N et al. Triple Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate Improves Inspiratory Capacity in Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap. Int J Chron Obstruct Pulmon Dis. 2020;15:269–277. https://doi.org/10.2147/COPD.S231004.; Rabe KF, Martinez FJ, Ferguson GT, Wang C, Singh D, Wedzicha JA et al. Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-VerySevere COPD. N Engl J Med. 2020;383(1):35–48. https://doi.org/10.1056/NEJMoa1916046.; Singh D, Rabe KF, Martinez FJ, Krüll M, Jenkins M, Patel M, Dorinsky P. Relationship between prior inhaled corticosteroid use and benefits ofbudesonide/glycopyrronium/formoterol fumarate dihydrate on exacerbations, symptoms, health-related quality of life, and lung function in patients with chronic obstructive pulmonary disease: Analyses from the ETHOS study. Respir Med. 2022;197:106857. https://doi.org/10.1016/j.rmed.2022.106857.; Martinez FJ, Rabe KF, Ferguson GT, Wedzicha JA, Singh D, Wang C et al. Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/ Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study. Am J Respir Crit Care Med. 2021;203(5):553–564. https://doi.org/10.1164/rccm.202006-2618OC.; Kolsum U, Damera G, Pham TH, Southworth T, Mason S, Karur P et al. Pulmonary inflammation in patients with chronic obstructive pulmonary disease with higher blood eosinophil counts. J Allergy Clin Immunol. 2017;140(4):1181–1184. https://doi.org/10.1016/j.jaci.2017.04.027.; Hasegawa K, Camargo CAJr. Prevalence of blood eosinophilia in hospitalized patients with acute exacerbation of COPD. Respirology. 2016;21(4):761–764. https://doi.org/10.1111/resp.12724.; Landis S, Suruki R, Maskell J, Bonar K, Hilton E, Compton C. Demographic and Clinical Characteristics of COPD Patients at Different Blood Eosinophil Levels in the UK Clinical Practice Research Datalink. COPD. 2018;15(2):177–184. https://doi.org/10.1080/15412555.2018.1441275.; Bacci E, Cianchetti S, Bartoli M, Dente FL, Di Franco A, Vagaggini B, Paggiaro P. Low sputum eosinophils predict the lack of response to beclomethasone in symptomatic asthmatic patients. Chest. 2006;129(3):565–572. https://doi.org/10.1378/chest.129.3.565.; Pizzichini E, Pizzichini MM, Gibson P, Parameswaran K, Gleich GJ, Berman L et al. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med. 1998;158(5):1511–1517. https://doi.org/10.1164/ajrccm.158.5.9804028.; Park HY, Lee H, Koh WJ, Kim S, Jeong I, Koo HK et al. Association of blood eosinophils and plasma periostin with FEV1 response after 3-month inhaled corticosteroid and long-acting beta2-agonist treatment in stable COPD patients. Int J Chron Obstruct Pulmon Dis. 2015;11:23–30. https://doi.org/10.2147/COPD.S94797.; Авдеев СН, Трушенко НВ, Мержоева ЗМ, Иванова МС, Кусраева ЭВ. Эозинофильное воспаление при хронической обструктивной болезни легких. Терапевтический архив. 2019;91(10):144–152. https://doi.org/10.26442/00403660.2019.10.000426.; Лещенко ИВ, Мещерякова АС. Современные возможности терапии ингаляционными глюкокортикостероидами пациентов с хронической обструктивной болезнью легких. Пульмонология. 2021;31(1):75–87. https://doi.org/10.18093/0869-0189-2021-31-1-75-87.; Bafadhel M, Rabe KF, Martinez FJ, Singh D, Darken P, Jenkins M et al. Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS. Int J Chron Obstruct Pulmon Dis. 2022;17:3061–3073. https://doi.org/10.2147/COPD.S374670.; Muro S, Sugiura H, Darken P, Dorinsky P. Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts. Respir Res. 2021;22(1):187. https://doi.org/10.1186/s12931-021-01773-1.; Marsh SE, Travers J, Weatherall M, Williams MV, Aldington S, Shirtcliffe PM et al. Proportional classification of COPD phenotypes. Thorax. 2008;63(9):761–767. https://doi.org/10.1136/thx.2007.089193.; Shaya FT, Dongyi D, Akazawa MO, Blanchette CM, Wang J, Mapel DW et al. Burden of concomitant asthma and COPD in a Medicaid population. Chest. 2008;134(1):14–19. https://doi.org/10.1378/chest.07-2317.; Hardin M, Silverman EK, Barr RG, Hansel NN, Schroeder JD, Make BJ et al. The clinical features of the overlap between COPD and asthma. Respir Res. 2011;12(1):127. https://doi.org/10.1186/1465-9921-12-127.; Park SY, Kim S, Kim JH, Kim SH, Lee T, Yoon SY et al. A Randomized, Noninferiority Trial Comparing ICS + LABA with ICS + LABA + LAMA in Asthma-COPD Overlap (ACO) Treatment: The ACO Treatment with Optimal Medications (ATOMIC) Study. J Allergy Clin Immunol Pract. 2021;9(3):1304–1311. https://doi.org/10.1016/j.jaip.2020.09.066.; Lipson DA, Barnhart F, Brealey N, Brooks J, Criner GJ, Day NC et al. Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD. N Engl J Med. 2018;378(18):1671–1680. https://doi.org/10.1056/NEJMoa1713901.; Papi A, Vestbo J, Fabbri L, Corradi M, Prunier H, Cohuet G et al. Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial. Lancet. 2018;391(10125):1076–1084. https://doi.org/10.1016/S0140-6736(18)30206-X.; Izquierdo JL, Cosio BG. The dose of inhaled corticosteroids in patients with COPD: when less is better. Int J Chron Obstruct Pulmon Dis. 2018;13:3539–3547. https://doi.org/10.2147/COPD.S175047.; Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847–852. https://doi.org/10.1136/thorax.57.10.847.; Cazzola M, Rogliani P, Laitano R, Calzetta L, Matera MG. Beyond Dual Bronchodilation – Triple Therapy, When and Why. Int J Chron Obstruct Pulmon Dis. 2022;17:165–180. https://doi.org/10.2147/COPD.S345263.; https://www.med-sovet.pro/jour/article/view/7877

الاتاحة: https://www.med-sovet.pro/jour/article/view/7877
https://doi.org/10.21518/ms2023-382

المؤلفون: I. V. Demko, N. V. Gordeeva, A. Yu. Kraposhina, M. G. Mamaeva, I. A. Soloveva

المصدر: Медицинский совет, Vol 0, Iss 21, Pp 90-95 (2021)

مصطلحات موضوعية: chronic obstructive pulmonary disease, bronchodilators, long acting beta agonists, long acting muscarinic antagonists, vilanterol, umeclidinium, olodaterol, tiotropium bromide, Medicine

وصف الملف: electronic resource

Relation: https://www.med-sovet.pro/jour/article/view/5970; https://doaj.org/toc/2079-701X; https://doaj.org/toc/2658-5790

URL الوصول: https://doaj.org/article/ae992e8264694b298879349c98d7dc0f

المؤلفون: Richard Beasley, James Harper, Grace Bird, Harriette Dunphy, Alex Semprini, Ian D. Pavord, Alberto Papi, Mark Weatherall

المصدر: BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-8 (2019)

مصطلحات موضوعية: Asthma, Dose-response relationships, Inhaled corticosteroids, Long acting beta agonists, Severe exacerbations, Diseases of the respiratory system, RC705-779

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1471-2466

URL الوصول: https://doaj.org/article/127ad60dad3d450ba34cda8ccaf3d542

المؤلفون: Shaikh, Aadil Ashraf Ahmed, Boniface, Mary Ann, Naeem, Nida, Ammar Husain, Syed, D Cruz, Leon Gerard, Husain, Syed Arshad

المصدر: Cureus ; ISSN:2168-8184 ; Volume:16 ; Issue:11

مصطلحات موضوعية: asthma, beclomethasone-formoterol, cough, inhaled corticosteroid, long acting beta agonists, mef-25, shortness of breath, small airway disease, spirometry, wheeze

Relation: https://doi.org/10.7759/cureus.74319; https://pubmed.ncbi.nlm.nih.gov/39717289; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11666259/

الاتاحة: https://doi.org/10.7759/cureus.74319
https://pubmed.ncbi.nlm.nih.gov/39717289
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11666259/

المؤلفون: Faeq R. Kukhon, Emir Festic

المصدر: Medical Sciences; Volume 9; Issue 2; Pages: 34

مصطلحات موضوعية: community-acquired pneumonia, inhaled corticosteroids, long-acting beta agonists, systemic corticosteroids

وصف الملف: application/pdf

Relation: Pneumology and Respiratory Diseases; https://dx.doi.org/10.3390/medsci9020034

الاتاحة: https://doi.org/10.3390/medsci9020034

المؤلفون: Fugui Yan, Wen Li, Wei‐jie Guan, Min Chen, Chen Qiu, Wei Tang, Xiansheng Liu, Xudong Xiang, Jing Li, Meiling Jin, Yuanrong Dai, Ping Chen, Xiaohong Wu, Zhongmin Qiu, Liang Dong, Limin Zhao, Xiaoping Lin, Changgui Wu, Bin Wu, Yalian Yuan, Fei Shi, Ting Zhang, Jun Zhou, Min Xie, Xiaoyu Fang, Hongliang Zhang, Bing Xiao, Mo Xian, Jian Wang, Zhangwei Qiu, Jie Lin, Bingbing Ji, Yong Zhou, Yu Li, Chunhong Liu, Yiping Chen, Yiming Zeng, Lingli Liu, Wen Hua, Huaqiong Huang, Jiesen Zhou, Yue Hu, Luanqing Che, Songmin Ying, Zhihua Chen, Nanshan Zhong, Huahao Shen

المصدر: Clinical and Translational Medicine, Vol 10, Iss 5, Pp n/a-n/a (2020)

مصطلحات موضوعية: chest tightness variant asthma, inhaled corticosteroids, long‐acting beta‐agonists, real‐world study, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2001-1326

URL الوصول: https://doaj.org/article/6354d8a6c3854933bd4ebe4f2d46df97

المؤلفون: Hongyu Wang, Melanie Kjarsgaard, Terence Ho, John D. Brannan, Parameswaran Nair

المصدر: Allergy, Asthma & Clinical Immunology, Vol 14, Iss 1, Pp 1-4 (2018)

مصطلحات موضوعية: Hypertonic saline, Sputum induction, Bronchoconstriction, Long-acting beta-agonists, Asthma, COPD, Immunologic diseases. Allergy, RC581-607

وصف الملف: electronic resource

Relation: http://link.springer.com/article/10.1186/s13223-018-0256-7; https://doaj.org/toc/1710-1492

URL الوصول: https://doaj.org/article/56daf4e985d84d0b8e99e3ca1d3ad725

المؤلفون: E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov, N. L. Bondarenko, A. V. Karaulov

المصدر: Фармакоэкономика, Vol 10, Iss 2, Pp 22-30 (2017)

مصطلحات موضوعية: chronic obstructive pulmonary disease, copd, long-acting beta-agonists, laba, long-acting anticholinergics, laac, vilantererol, umeclidinum bromide, olodaterol, tiotropium bromide, fixed combination, cost minimization analysis, cost-effectiveness analysis, budget impact analysis, Therapeutics. Pharmacology, RM1-950, Economics as a science, HB71-74

وصف الملف: electronic resource

Relation: https://www.pharmacoeconomics.ru/jour/article/view/196; https://doaj.org/toc/2070-4909; https://doaj.org/toc/2070-4933

URL الوصول: https://doaj.org/article/1d4f89ad2f9c43b4acf1d67df41135bb

المؤلفون: N. L. Pogudina, E. G. Kosolapov, F. S. Kochenkov, A. V. Karaulov, N. L. Bondarenko, D. V. Blinov

المصدر: Фармакоэкономика, Vol 10, Iss 2, Pp 12-21 (2017)

مصطلحات موضوعية: asthma, inhaled corticosteroids, ics, long-acting beta agonists, laba, vilanterol, fluticasone furoate, budesonide, formoterol, fixed-dose combination, cost-minimization analysis, budget impact analysis, Therapeutics. Pharmacology, RM1-950, Economics as a science, HB71-74

وصف الملف: electronic resource

Relation: https://www.pharmacoeconomics.ru/jour/article/view/195; https://doaj.org/toc/2070-4909; https://doaj.org/toc/2070-4933

URL الوصول: https://doaj.org/article/510e92d40fef4d478021f3c82e9a7a72

المؤلفون: E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov

المصدر: Фармакоэкономика, Vol 10, Iss 2, Pp 31-40 (2017)

مصطلحات موضوعية: chronic obstructive pulmonary disease, copd, long-acting beta-agonists, laac, long-acting anticholinergics, vilantererol, umeclidinum bromide, tiotropium bromide, cost-effectiveness analysis, cost-utility analysis, budget impact analysis, Therapeutics. Pharmacology, RM1-950, Economics as a science, HB71-74

وصف الملف: electronic resource

Relation: https://www.pharmacoeconomics.ru/jour/article/view/197; https://doaj.org/toc/2070-4909; https://doaj.org/toc/2070-4933

URL الوصول: https://doaj.org/article/45a3d1dabd4645ce9114c79e5fe8b0e7

المؤلفون: Rodrigo, Gustavo Javier, Plaza Moral, Vicente, García-Marcos, Luis, Castro Rodríguez, José Antonio

مصطلحات موضوعية: Asthma, Bronchodilators, Formoterol, Inhaled corticosteroids, Long-acting beta agonists, Safety, Salmeterol, Medicina y salud

Time: 610

Relation: Pulmonary Pharmacology and Therapeutics, vol. 22, no. 1 (feb. 2009), pp. 9-19.; https://www.doi.org/10.1016/j.pupt.2008.10.008; http://www.scopus.com/inward/record.url?eid=2-s2.0-58749100633&partnerID=MN8TOARS; https://repositorio.uc.cl/handle/11534/63166

الاتاحة: https://repositorio.uc.cl/handle/11534/63166
https://doi.org/10.1016/j.pupt.2008.10.008
http://www.scopus.com/inward/record.url?eid=2-s2.0-58749100633&partnerID=MN8TOARS

المؤلفون: R. Agarwal, A. Khan, A.N. Aggarwal, D. Gupta

المصدر: Monaldi Archives for Chest Disease, Vol 71, Iss 4 (2016)

مصطلحات موضوعية: Bronchial asthma, Single inhaler, SMART approach, Inhaled corticosteroids, Long-acting beta agonists, Medicine

وصف الملف: electronic resource

Relation: https://www.monaldi-archives.org/index.php/macd/article/view/348; https://doaj.org/toc/1122-0643; https://doaj.org/toc/2532-5264

URL الوصول: https://doaj.org/article/95a89ba83f434aecb71668cde0dddd2b

المؤلفون: Emir Festic, Faeq R Kukhon

المصدر: Medical Sciences
Medical Sciences, Vol 9, Iss 34, p 34 (2021)

مصطلحات موضوعية: medicine.medical_specialty, community-acquired pneumonia, medicine.medical_treatment, Anti-Inflammatory Agents, Inhaled corticosteroids, Review, Lung injury, long-acting beta agonists, law.invention, 03 medical and health sciences, 0302 clinical medicine, Immune system, Randomized controlled trial, Community-acquired pneumonia, law, Adrenal Cortex Hormones, medicine, Humans, 030212 general & internal medicine, Intensive care medicine, Glucocorticoids, Adjuvants, Pharmaceutic, business.industry, Pneumonia, medicine.disease, systemic corticosteroids, Review article, respiratory tract diseases, Community-Acquired Infections, 030228 respiratory system, Medicine, inhaled corticosteroids, business, Adjuvant

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf73af77486d243c4b62a581c65e9446
https://pubmed.ncbi.nlm.nih.gov/34071031

المؤلفون: Hernández, Gimena, Ávila Pacheco, Mónica Marcela, 1984-, Pont Acuña, Àngels, Garin Boronat, Olatz, 1979-, Alonso Caballero, Jordi, Laforest, Laurent, Cates, Christopher J., Ferrer Forés, Maria Montserrat, ASTRO-LAB group

مصطلحات موضوعية: Asma -- Epidemiologia, Asma -- Diagnòstic, Asma -- Tractament, Asthma, Long-acting beta-agonists, Inhaled corticosteroids, LABAs, Serious adverse events, Exacerbations

وصف الملف: application/pdf

Relation: Respiratory Research. 2014;15:83; info:eu-repo/grantAgreement/EC/FP7/282593; http://hdl.handle.net/10230/23856

الاتاحة: http://hdl.handle.net/10230/23856
https://doi.org/10.1186/1465-9921-15-83

المؤلفون: Usmani, OS

المساهمون: National Institute for Health Research

المصدر: 388 ; 376

مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Allergy, Immunology, Small airways, asthma, physiology, pharmacology, inhalation, aerosols, corticosteroids, long-acting beta agonists, OBSTRUCTIVE PULMONARY-DISEASE, SEVERE PERSISTENT ASTHMA, METERED-DOSE INHALER, CHLOROFLUOROCARBON BECLOMETHASONE DIPROPIONATE, LONG-ACTING BETA(2)-AGONIST, ONCE-DAILY CICLESONIDE, ALVEOLAR NITRIC-OXIDE, HIGH LUNG DEPOSITION, QUALITY-OF-LIFE, FLUTICASONE PROPIONATE

Relation: Allergy, asthma & immunology research; http://hdl.handle.net/10044/1/87060; CDF-2011-04-053

الاتاحة: http://hdl.handle.net/10044/1/87060
https://doi.org/10.4168/aair.2014.6.5.376

المؤلفون: Yong Zhou, Wei‐jie Guan, Songmin Ying, Ting Zhang, Hongliang Zhang, Jian Wang, Jing Li, Bin Wu, Yue Hu, Yuanrong Dai, Jie Lin, Xiaohong Wu, Zhangwei Qiu, Wen Li, Zhihua Chen, Limin Zhao, Xiaoyu Fang, Zhongmin Qiu, Changgui Wu, Jun Zhou, Huahao Shen, Bing Xiao, Chen Qiu, Wen Hua, Ping Chen, Xiaoping Lin, Fei Shi, Nanshan Zhong, Lingli Liu, Meiling Jin, Yiming Zeng, Mo Xian, Yu Li, Yiping Chen, Chunhong Liu, Bingbing Ji, Min Chen, Wei Tang, Yalian Yuan, Liang Dong, Min Xie, Jiesen Zhou, Huaqiong Huang, Luanqing Che, Fugui Yan, Xudong Xiang, Xiansheng Liu

المصدر: Clinical and Translational Medicine, Vol 10, Iss 5, Pp n/a-n/a (2020)
Clinical and Translational Medicine

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Medicine (General), Medicine (miscellaneous), Subgroup analysis, chest tightness variant asthma, Letter to Editor, 03 medical and health sciences, FEV1/FVC ratio, 0302 clinical medicine, R5-920, Internal medicine, Eosinophilic, Medicine, Asthma, business.industry, Therapeutic effect, long‐acting beta‐agonists, medicine.disease, Regimen, 030104 developmental biology, Asthma Control Questionnaire, 030220 oncology & carcinogenesis, real‐world study, Molecular Medicine, Chest tightness, inhaled corticosteroids, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b853715ba1483bfb5589c9ed5529adc8
https://doaj.org/article/6354d8a6c3854933bd4ebe4f2d46df97

المؤلفون: F. S. Kochenkov, N. L. Bondarenko, A. V. Karaulov, E. G. Kosolapov, D. V. Blinov, N. L. Pogudina

المصدر: Фармакоэкономика, Vol 10, Iss 2, Pp 22-30 (2017)

مصطلحات موضوعية: medicine.medical_specialty, fixed combination, RM1-950, chronic obstructive pulmonary disease, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Bromide, medicine, tiotropium bromide, budget impact analysis, 030223 otorhinolaryngology, HB71-74, Pharmacology, cost minimization analysis, COPD, vilantererol, business.industry, laac, olodaterol, Health Policy, Olodaterol, Public Health, Environmental and Occupational Health, cost-effectiveness analysis, copd, Tiotropium bromide, Cost-effectiveness analysis, medicine.disease, Clinical trial, long-acting beta-agonists, Economics as a science, chemistry, umeclidinum bromide, Emergency medicine, Cost-minimization analysis, long-acting anticholinergics, laba, Vilanterol, Therapeutics. Pharmacology, business, 030217 neurology & neurosurgery, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68e2b340f150ad9be9f04351c24e2800
https://www.pharmacoeconomics.ru/jour/article/view/196